Patent · US Active

2,3,4,5-tetrahydro-1H-pyrido[4,3-B]indole compounds and methods of use thereof

US9115137B2 · kind B2 · utility

10Cited by
20References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 26, 2009
Grant dateAug 25, 2015
Priority date
Expiry dateJan 1, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are new tricyclic compounds that may be used to modulate a histamine receptor in an individual. Compounds are described, including new 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole compounds. Pharmaceutical compositions comprising the compounds are also provided, as are methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.